ARCHIVES

Phase III Study Evaluating Halaven Fails To Meet Primary Endpoints

This article is from The Cancer Letter archive.

Vol. 35 No. 7 | July 27, 2012

Download PDF Visit The Full Archive

Related Articles

NCAB Jolted By 1977 Prelim Budget, “Outrageous” Prospect – Funding Only 30% Of Approved Grants

June 27, 1975

Avastin Improves Survival By 30 Percent In Advanced Non-Small Cell Lung Cancer

June 24, 2005

Other ASCO Plenary Papers: Long Awaited Chemotherapy Results

June 12, 1992

In Brief: Potter New AACI President, Sartorlli President Elect; NCI Staffers Get NIH Director’s Award

July 18, 1986

Decision to Cover New Colorectal Cancer Drugs, PET Scans.

February 4, 2005

Advisors OK Planning Grants In Breast Cancer For Cancer Centers

July 9, 1993